a year ago

Neurovalens Secures £2.1 Million to Bring Wearable Anxiety Treatment to US Market

  • Belfast-based health tech startup Neurovalens has raised £2.1 million in funding to support the US expansion of its wearable anxiety treatment, Modius Stress

  • The headband, recently FDA-approved as a medical device for generalized anxiety disorder, uses electronic brain stimulation to reduce anxiety

  • The funding round saw participation from previous backers, including MedTech Innovator and Invest Northern Ireland.

      • ProblemHealthcare

      "Millions of people suffer from anxiety, a debilitating condition that negatively impacts their daily lives."

      Solution

      "We have developed a wearable headband that uses neurostimulation to reduce anxiety. Our technology is non-invasive, drug-free, and has been approved by regulatory bodies."

      Covered on